The following antibodies were used: mouse monoclonal anti-paxillin antibody (Cat#610620, BD Biosciences, San Jose, CA, USA), anti-paxillin polyclonal antibody (H85, Santa Cruz, Dallas, CA, USA), anti-GAPDH monoclonal antibody (Wako, Osaka, Japan), anti-phospho-MYPT1 (T850) with phosphorylation site corresponding to T853 in human MYPT1 (Milipore, Burlington, CA, USA), anti-MYPT1 antibody (H130, Santa Cruz, Dallas, CA, USA), anti-phospho-myosin light chain 2 (S19) monoclonal antibody (Cell Signaling, Danvers, MA, USA), anti-myosin light chain (20 kDa) monoclonal antibody (Sigma Aldrich, St. Louis, MO, USA), anti-α-smooth muscle actin antibody (Thermo Fisher, Waltham, MA, USA), anti-mouse Alexa Fluor 488 (Thermo Fisher, Waltham, MA, USA), and anti-rabbit Alexa Fluor 546 (Thermo Fisher,Waltham, MA, USA). Secondary HRP-labeled antibodies (anti-mouse and anti-rabbit) were purchased from Promega (Madison, WI, USA).
Anti myosin light chain 20 kda monoclonal antibody
The Anti-myosin light chain (20 kDa) monoclonal antibody is a laboratory reagent used in research applications. It specifically binds to the 20 kDa myosin light chain protein. This antibody can be used for the detection and analysis of the target protein in various experimental techniques.
Lab products found in correlation
2 protocols using anti myosin light chain 20 kda monoclonal antibody
Phospho-protein signaling pathway analysis
The following antibodies were used: mouse monoclonal anti-paxillin antibody (Cat#610620, BD Biosciences, San Jose, CA, USA), anti-paxillin polyclonal antibody (H85, Santa Cruz, Dallas, CA, USA), anti-GAPDH monoclonal antibody (Wako, Osaka, Japan), anti-phospho-MYPT1 (T850) with phosphorylation site corresponding to T853 in human MYPT1 (Milipore, Burlington, CA, USA), anti-MYPT1 antibody (H130, Santa Cruz, Dallas, CA, USA), anti-phospho-myosin light chain 2 (S19) monoclonal antibody (Cell Signaling, Danvers, MA, USA), anti-myosin light chain (20 kDa) monoclonal antibody (Sigma Aldrich, St. Louis, MO, USA), anti-α-smooth muscle actin antibody (Thermo Fisher, Waltham, MA, USA), anti-mouse Alexa Fluor 488 (Thermo Fisher, Waltham, MA, USA), and anti-rabbit Alexa Fluor 546 (Thermo Fisher,Waltham, MA, USA). Secondary HRP-labeled antibodies (anti-mouse and anti-rabbit) were purchased from Promega (Madison, WI, USA).
DPA and SPC Signaling Pathway Characterization
The following antibodies were used: anti-phospho-MYPT1 (Thr850) with phosphorylation site corresponding to Thr853 in human MYPT1 (Upstate), anti-GAPDH monoclonal antibody (Wako), anti-phospho-myosin light chain 2 (Ser19) monoclonal antibody (Cell Signaling), anti-myosin light chain (20 kDa) monoclonal antibody (Sigma Aldrich), anti-Rho-kinase-2 polyclonal antibody (H85, Santa Cruz), and anti-rabbit Alexa Fluor 488 (Thermo Fisher). Secondary HRP-labeled antibodies (anti-mouse and anti-rabbit) were purchased from Promega.
About PubCompare
Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.
We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.
However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.
Ready to get started?
Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required
Revolutionizing how scientists
search and build protocols!